CD4 and tuberculosis: Other possible limitations of this population-based study include the limited access to clinical data such as HAART treatment and CD4 cell count, the limited presence of sub-populations who are usually culture negative such as children, and the absence of appropriate molecular techniques to determine if recurrence was due to reactivation of the same TB strain or due to re-infection by a different strain [44].